logo

Novartis Ag (NVS)



Trade NVS now with
  Date
  Headline
8/2/2021 9:31:32 AM Lp HORIZON Achieves 50% Enrollment In Trial To Assess Efficacy Of Pelacarsen In Reducing Recurrent Cardiovascular Events
7/21/2021 1:03:11 AM Novartis Q2 EPS $1.29; Core EPS $1.66
7/6/2021 7:36:27 AM Kura Oncology Announces Clinical Collaboration With Novartis To Evaluate Tipifarnib In Combination With Alpelisib
6/28/2021 1:22:35 AM Novartis Appoints Rob Kowalski As Chief People & Organization Officer
6/4/2021 10:38:15 AM Novartis Announces Tabrecta First Published Overall Survival &updated Overall Response Data In METex14 Metastatic NSCLC
6/2/2021 9:59:35 AM Novartis Kymriah Trial Shows Strong Response Rates And Safety Profile In R/r Follicular Lymphoma
5/17/2021 11:06:21 AM US Supreme Court Denies Sandoz Petition To Review Biosimilar Erelzi Case
5/3/2021 1:17:38 AM Sandoz Confirms Late-stage Clinical Development Plans For Proposed Biosimilar Aflibercept